SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-339697
Filing Date
2011-12-13
Accepted
2011-12-13 17:18:31
Documents
3
Period of Report
2011-12-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d267961d8k.htm 8-K 15338
2 PRESS RELEASE ISSUED BY THE REGISTRANT ON DECEMBER 7, 2011 d267961dex991.htm EX-99.1 9027
3 GRAPHIC g267961g03m92.jpg GRAPHIC 9591
  Complete submission text file 0001193125-11-339697.txt   39057
Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34921 | Film No.: 111259197
SIC: 2834 Pharmaceutical Preparations